Bollard Group’s ICU Medical ICUI Stock Holding History

Bollard Group’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-407	Closed	-$91K	–	341
2022 Q1	$91K	Hold	407	–	–	﹤0.01%	292
2021 Q4	$97K	Hold	407	–	–	﹤0.01%	294
2021 Q3	$95K	Hold	407	–	–	﹤0.01%	287
2021 Q2	$84K	Hold	407	–	–	﹤0.01%	301
2021 Q1	$84K	Hold	407	–	–	﹤0.01%	295
2020 Q4	$87K	Hold	407	–	–	﹤0.01%	284
2020 Q3	$74K	Hold	407	–	–	﹤0.01%	284
2020 Q2	$75K	Buy	+407	New	+$80.8K	﹤0.01%	290

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Bollard Group's ICUI Position: Q2 2022 in Review

Bollard Group sold out of ICU Medical (ICUI) in Q2 2022, closing a stake of 407 shares — an estimated $91K sold.

Bollard Group first reported a position in ICUI in Q2 2020 and held it in 8 quarters. The position peaked at $97K in Q4 2021. 258 funds tracked by Wall St. Rank hold ICUI as of Q2 2022.

Bollard Group reported no remaining ICU Medical position as of Q2 2022 after selling out during the quarter.
Bollard Group sold 407 ICU Medical shares in Q2 2022, an estimated $91K.
Bollard Group first reported a position in ICU Medical in Q2 2020 and held it in 8 quarters.
Bollard Group's ICU Medical position peaked at $97K in Q4 2021.
258 funds tracked by Wall St. Rank held ICU Medical as of Q2 2022.

Based on Bollard Group's 13F filing for Q2 2022, filed 12 Aug 2022.